Bing‐Neel syndrome

Authors: Katelynn Davis, William H. Sharfman, Ivo M. B. Francischetti

Source: eJHaem, Vol 3, Iss 4, Pp 1425-1426 (2022)

Subject Terms: ibrutinib, lymphoplasmacytic lymphoma, Waldenström's macroglobulinemia, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2688-6146

Access URL: https://doaj.org/article/6dbda922405e4c57aeabd1ed058edd85

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

Authors: Jaclyn LoPiccolo, Megan D. Schollenberger, Sumia Dakhil, Samuel Rosner, Osama Ali, William H. Sharfman, Ann W. Silk, Shailender Bhatia, Evan J. Lipson

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-5 (2019)

Subject Terms: Merkel cell carcinoma, Anti-PD-1-refractory, Progression, Immune checkpoint blockers, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0661-6; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/7b45f8f72c13410fbc81486bdc94fbae

An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma

Authors: Merve Hasanov, Denái R. Milton, William H. Sharfman, Bret Taback, Lee D. Cranmer, Gregory A Daniels, Lawrence Flaherty, Sigrun Hallmeyer, Mohammed Milhem, Lynn Feun, Ralph Hauke, Gary Doolittle, Nancy Gregory, Sapna Patel

Source: OncoImmunology, Vol 10, Iss 1 (2021)

Subject Terms: metastatic melanoma, ipilimumab, high dose interleukin-2, clinical trial, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2162-402X

Access URL: https://doaj.org/article/8301b9196dbd4b3ab906e344ff9c4301

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Authors: Kellie N. Smith, Nicolas J. Llosa, Tricia R. Cottrell, Nicholas Siegel, Hongni Fan, Prerna Suri, Hok Yee Chan, Haidan Guo, Teniola Oke, Anas H. Awan, Franco Verde, Ludmila Danilova, Valsamo Anagnostou, Ada J. Tam, Brandon S. Luber, Bjarne R. Bartlett, Laveet K. Aulakh, John-William Sidhom, Qingfeng Zhu, Cynthia L. Sears, Leslie Cope, William H. Sharfman, Elizabeth D. Thompson, Joanne Riemer, Kristen A. Marrone, Jarushka Naidoo, Victor E. Velculescu, Patrick M. Forde, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Jennifer N. Durham, Hao Wang, Dung T. Le, Sune Justesen, Janis M. Taube, Luis A. Diaz, Julie R. Brahmer, Drew M. Pardoll, Robert A. Anders, Franck Housseau

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)

Subject Terms: Checkpoint blockade, Predictive biomarkers, Oncogene, Neoantigens, T cells, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-018-0492-x; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/1bbf8602f6f8428183fdc7d49f984cca

From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting

Authors: Steven P. Rowe, Brandon Luber, Monique Makell, Patricia Brothers, JoAnn Santmyer, Megan D. Schollenberger, Hannah Quinn, Daniel L. Edelstein, Frederick S. Jones, Karen B. Bleich, William H. Sharfman, Evan J. Lipson

Source: Molecular Oncology, Vol 12, Iss 10, Pp 1661-1672 (2018)

Subject Terms: circulating tumor DNA, ctDNA, melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1574-7891; https://doaj.org/toc/1878-0261

Access URL: https://doaj.org/article/c97ee8a332b34e88b8e3793b4d13f425

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

Authors: Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

Source: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-9 (2018)

Subject Terms: Immunotherapy, Immune-related adverse events, Bone resorption, Fracture, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-018-0417-8; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/21b13354a7f847f6bea97136a6b651e1

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Authors: Kellie N. Smith, Nicolas J. Llosa, Tricia R. Cottrell, Nicholas Siegel, Hongni Fan, Prerna Suri, Hok Yee Chan, Haidan Guo, Teniola Oke, Anas H. Awan, Franco Verde, Ludmila Danilova, Valsamo Anagnostou, Ada J. Tam, Brandon S. Luber, Bjarne R. Bartlett, Laveet K. Aulakh, John-William Sidhom, Qingfeng Zhu, Cynthia L. Sears, Leslie Cope, William H. Sharfman, Elizabeth D. Thompson, Joanne Riemer, Kristen A. Marrone, Jarushka Naidoo, Victor E. Velculescu, Patrick M. Forde, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Jennifer N. Durham, Hao Wang, Dung T. Le, Sune Justesen, Janis M. Taube, Luis A. Diaz Jr, Julie R. Brahmer, Drew M. Pardoll, Robert A. Anders, Franck Housseau

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-2 (2019)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0547-7; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/53de6d1b2ed144d48e2c742123df82a4

Primary Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses

Authors: Maliha Khan, Sobia Nizami, Aibek E. Mirrakhimov, Benjamin Maughan, Justin A. Bishop, William H. Sharfman

Source: Case Reports in Medicine, Vol 2014 (2014)

Subject Terms: Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1687-9627; https://doaj.org/toc/1687-9635

Access URL: https://doaj.org/article/5b763f82dc704bcf8ea010a9cec09153

This result is not displayed to guests.
Login for full access.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Authors: Erin Jensen, Evan J Lipson, Martin A Cheever, Adil Daud, Brent A Hanks, Shailender Bhatia, Thomas Olencki, Kari Kendra, Mizuho Kalabis, William H Sharfman, Ragini R Kudchadkar, Philip A Friedlander, Sunil A Reddy, Brian C Boulmay, Adam Riker, Melissa A Burgess, Candice Church, Tomoko Akaike, Michi M Shinohara, Bob Salim, Blanca Homet Moreno

Source: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/9/4/e002478.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/73de26009f964e2780583bb59aad23b0

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy

Authors: Mariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, Lee D Cranmer, Clara Curiel-Lewandrowski, Vernon K Sondak, Clara E Stemwedel, Susan M Swetter, John Vetto, Tawnya Bowles, Robert P Dellavalle, Larisa J Geskin, Douglas Grossman, Kenneth F Grossmann, Jason E Hawkes, Joanne M Jeter, Caroline C Kim, John M Kirkwood, Aaron R Mangold, Frank Meyskens, Michael E Ming, Kelly C Nelson, Michael Piepkorn, Brian P Pollack, June K Robinson, Arthur J Sober, Shannon Trotter, Suraj S Venna, Sanjiv Agarwala, Rhoda Alani, Bruce Averbook, Anna Bar, Mirna Becevic, Neil Box, William E Carson, Pamela B Cassidy, Suephy C Chen, Emily Y Chu, Darrel L Ellis, Laura K Ferris, David E Fisher, Kari Kendra, David H Lawson, Philip D Leming, Kim A Margolin, Svetomir Markovic, Mary C Martini, Debbie Miller, Debjani Sahni, William H Sharfman, Jennifer Stein, Alexander J Stratigos, Ahmad Tarhini, Matthew H Taylor, Oliver J Wisco, Michael K Wong

Source: Melanoma Management, Vol 4, Iss 1, Pp 13-37 (2017)

Subject Terms: early detection, guidelines, keratinocyte carcinoma, melanoma, melanoma odds ratio, melanoma relative risk, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-0885; https://doaj.org/toc/2045-0893

Access URL: https://doaj.org/article/8e14d4bd2ae34bdfbf467c03771d28b3